Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge

Tumefactive demyelinating lesion is defined as large solitary demyelinating lesion with imaging characteristics mimicking neoplasm. These atypical features include size more than 2 cm, mass effect, edema, and/or ring enhancement. Distinguishing tumefactive lesions from other etiologies of intracrani...

Full description

Bibliographic Details
Main Authors: Hossein Kalanie, Ali Amini Harandi, Reza Bakhshandehpour, Daryoosh Heidari
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Case Reports in Radiology
Online Access:http://dx.doi.org/10.1155/2012/363705
id doaj-8999bf0d10dc47b294ef304378ea3af0
record_format Article
spelling doaj-8999bf0d10dc47b294ef304378ea3af02020-11-24T23:03:46ZengHindawi LimitedCase Reports in Radiology2090-68622090-68702012-01-01201210.1155/2012/363705363705Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic ChallengeHossein Kalanie0Ali Amini Harandi1Reza Bakhshandehpour2Daryoosh Heidari3Mehr Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranLoghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranShahid Beheshti University of Medical Sciences, Tehran, IranMehr Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranTumefactive demyelinating lesion is defined as large solitary demyelinating lesion with imaging characteristics mimicking neoplasm. These atypical features include size more than 2 cm, mass effect, edema, and/or ring enhancement. Distinguishing tumefactive lesions from other etiologies of intracranial space occupying lesions is essential to avoid inadvertent surgical or toxic chemotherapeutic intervention. Symptoms are generally atypical for multiple sclerosis (MS) and usually related to the pressure of a focal mass lesion without a history of MS. The clinical presentation and MRI appearance of these lesions often lead to biopsy. Here, we present a young man with fulminating neurological symptoms and multiple large tumefactive lesions on either hemisphere. Since patient and parents were not agreed on brain biopsy, a course of steroid therapy was commenced which ended to considerable improvement and confirmed the diagnosis of tumefactive MS. Thirteen months later, he experienced another relapse when his treatment was continued by weekly intramuscular injection of interferon b1a (Avonex). Two further MRIs showed shrinkage of tumefactive plaques and resolution of edema in the periphery of lesions.http://dx.doi.org/10.1155/2012/363705
collection DOAJ
language English
format Article
sources DOAJ
author Hossein Kalanie
Ali Amini Harandi
Reza Bakhshandehpour
Daryoosh Heidari
spellingShingle Hossein Kalanie
Ali Amini Harandi
Reza Bakhshandehpour
Daryoosh Heidari
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
Case Reports in Radiology
author_facet Hossein Kalanie
Ali Amini Harandi
Reza Bakhshandehpour
Daryoosh Heidari
author_sort Hossein Kalanie
title Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
title_short Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
title_full Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
title_fullStr Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
title_full_unstemmed Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
title_sort multiple large tumefactive ms plaques in a young man: a diagnostic enigma and therapeutic challenge
publisher Hindawi Limited
series Case Reports in Radiology
issn 2090-6862
2090-6870
publishDate 2012-01-01
description Tumefactive demyelinating lesion is defined as large solitary demyelinating lesion with imaging characteristics mimicking neoplasm. These atypical features include size more than 2 cm, mass effect, edema, and/or ring enhancement. Distinguishing tumefactive lesions from other etiologies of intracranial space occupying lesions is essential to avoid inadvertent surgical or toxic chemotherapeutic intervention. Symptoms are generally atypical for multiple sclerosis (MS) and usually related to the pressure of a focal mass lesion without a history of MS. The clinical presentation and MRI appearance of these lesions often lead to biopsy. Here, we present a young man with fulminating neurological symptoms and multiple large tumefactive lesions on either hemisphere. Since patient and parents were not agreed on brain biopsy, a course of steroid therapy was commenced which ended to considerable improvement and confirmed the diagnosis of tumefactive MS. Thirteen months later, he experienced another relapse when his treatment was continued by weekly intramuscular injection of interferon b1a (Avonex). Two further MRIs showed shrinkage of tumefactive plaques and resolution of edema in the periphery of lesions.
url http://dx.doi.org/10.1155/2012/363705
work_keys_str_mv AT hosseinkalanie multiplelargetumefactivemsplaquesinayoungmanadiagnosticenigmaandtherapeuticchallenge
AT aliaminiharandi multiplelargetumefactivemsplaquesinayoungmanadiagnosticenigmaandtherapeuticchallenge
AT rezabakhshandehpour multiplelargetumefactivemsplaquesinayoungmanadiagnosticenigmaandtherapeuticchallenge
AT daryooshheidari multiplelargetumefactivemsplaquesinayoungmanadiagnosticenigmaandtherapeuticchallenge
_version_ 1725632184352505856